Atbtherapeutics
1 known investors
ATB Therapeutics develops targeted antibody therapies, including its "atbody" format, for hematological malignancies, autoimmune diseases, and solid tumors. The company also operates a plant-based manufacturing technology platform for producing these therapeutics.